Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341-350].
Jeong JH, Kim JE, Ahn JH, Jung KH, Koh SJ, Cheon J, Sohn J, Kim GM, Lee KS, Sim SH, Park IH, Kim SB. Jeong JH, et al. Among authors: kim sb, kim gm, kim je. Eur J Cancer. 2021 May;148:451-452. doi: 10.1016/j.ejca.2021.02.004. Epub 2021 Mar 7. Eur J Cancer. 2021. PMID: 33750608 No abstract available.
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.
Kim CG, Sohn J, Chon H, Kim JH, Heo SJ, Cho H, Kim IJ, Kim SI, Park S, Park HS, Kim GM. Kim CG, et al. Among authors: kim ij, kim si, kim gm, kim jh. J Breast Cancer. 2016 Mar;19(1):76-82. doi: 10.4048/jbc.2016.19.1.76. Epub 2016 Mar 25. J Breast Cancer. 2016. PMID: 27064666 Free PMC article.
Chemotherapy-induced irreversible alopecia in early breast cancer patients.
Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, Kim SI, Kim D, Sohn J. Kim GM, et al. Among authors: kim jy, kim d, kim s, kim si. Breast Cancer Res Treat. 2017 Jun;163(3):527-533. doi: 10.1007/s10549-017-4204-x. Epub 2017 Mar 21. Breast Cancer Res Treat. 2017. PMID: 28324267
Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results.
Park HS, Park SJ, Kim JY, Kim S, Ryu J, Sohn J, Park S, Kim GM, Hwang IS, Choi JR, Kim SI. Park HS, et al. Among authors: kim jy, kim s, kim gm, kim si. Ann Surg Treat Res. 2017 May;92(5):331-339. doi: 10.4174/astr.2017.92.5.331. Epub 2017 Apr 27. Ann Surg Treat Res. 2017. PMID: 28480178 Free PMC article.
Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Park S, Koo JS, Kim GM, Sohn J, Kim SI, Cho YU, Park BW, Park VY, Yoon JH, Moon HJ, Kim MJ, Kim EK. Park S, et al. Among authors: kim gm, kim si, kim ek, kim mj. Cancer Res Treat. 2018 Jul;50(3):801-812. doi: 10.4143/crt.2017.210. Epub 2017 Aug 17. Cancer Res Treat. 2018. PMID: 28814071 Free PMC article.
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
Park YH, Im SA, Kim SB, Sohn JH, Lee KS, Chae YS, Lee KH, Kim JH, Im YH, Kim JY, Kim TY, Lee KH, Ahn JH, Kim GM, Park IH, Lee SJ, Han HS, Kim SH, Jung KH; Korean Cancer Study Group (KCSG). Park YH, et al. Among authors: kim sb, kim jy, kim ty, kim sh, kim gm, kim jh. Eur J Cancer. 2017 Nov;86:385-393. doi: 10.1016/j.ejca.2017.10.002. Epub 2017 Nov 5. Eur J Cancer. 2017. PMID: 29100193 Clinical Trial.
638 results